SEC Form 4 · accession 0001835966-26-000006
Revolution Medicines, Inc. · RVMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan B. Sandler
Officer — Chief Development Officer
Period of report
Sep 16, 2026
Accepted (ET)
Sep 18, 2026 · 6:06 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001628171
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Sep 16, 2026 | S | 5 | $194.9589 | D | 53,204 | D | |
| Common StockF3 | Sep 16, 2026 | S | 336 | $199.3032 | D | 52,868 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on June 13, 2026 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units.
- F2Includes 209 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2026.
- F3Includes 52,350 restricted stock units.